This advisory highlights more than 100 poster abstracts that will be presented at ASH 2025 involving researchers ...

Immix Biopharma, Inc. is building strength in its pipeline with impressive early signals in AL amyloidosis. Learn more about ...

Doctors closely monitor myeloma. The tests you have and how often you have them depend on your situation. You might have regular appointments and tests to: monitor myeloma without symptoms ...

Regulatory momentum builds for bexobrutideg with multiple designations across the United States and EU, Including EMA PRIME and FDA Fast Track for CLL/SLL SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) ...

The term paraproteinemic neuropathy describes a heterogeneous set of neuropathies characterized by the presence of homogeneous immunoglobulin in the serum. An abnormal clonal proliferation of ...

Background: Guidelines recommend the use of technetium-99 m pyrophosphate (PYP) scanning after light chain amyloidosis has been ruled out via laboratory testing. Yet lack of execution of this ...

Key clinical findings that distinguish POEMS syndrome from CIDP are the presence of lambda paraprotein and predominantly lower extremity neuropathy. The diagnostic challenge posed by the differential ...

Celebrity Big Brother star Louis Walsh has opened up about battling a rare form of blood cancer, which around 350 in the UK are diagnosed with every year. The former X Factor judge was diagnosed with ...

Myeloma is a type of blood cancer that develops from plasma cells in the bone marrow. Plasma cells are a type of blood cell that makes antibodies to fight infection. The bone marrow makes them. In ...

Patients with immunoglobulin M (IgM) monoclonal gammopathy of undetermined significance (MGUS) can develop IgM-related disorders, such as cold agglutinin disease (CAD), peripheral neuropathy, and/or ...

Monoclonal gammopathy of renal significance (MGRS) includes smoldering B cell or plasma cell clones causing renal disease. Our understanding of MGRS is still evolving and through our study we intend ...